Whistleblower Exposes Internal Email Suggesting Pfizer Offered “Separate and Distinct” COVID-19 Vaccines to Employees

Credit: InfoWars

A whistleblower from Pfizer has leaked an internal email indicating that the pharmaceutical giant offered a “separate and distinct” COVID-19 vaccine to employees at its Pearl River research site in Rockland County, New York, InfoWars reported.

The email, dated January 2021, reassures  Pfizer employees that the vaccine supply for this internal program would not affect the doses committed to national governments worldwide.

According to the leaked document, site-essential workers were identified to receive these exclusive vaccinations.

According to the whistleblower, there was a widespread belief among employees that they were receiving vaccines that were different from those distributed to the public.

“I know we employees at Pfizer were receiving different vaccines and/or placebos, and this was the word around my site when I worked there,” the whistleblower told Infowars.

Pfizer whistleblower (Credit: InfoWars)

The email read:

I am pleased to inform you that we will begin offering COVID-19 vaccinations to eligible on-site essential colleagues and contractors over the next several weeks. As you are aware, Site-essential colleagues are the colleagues and contractors based at PGS [Pfizer Global Supply] and WRDM/GPD [Worldwide Research, Development, and Medical / Global Product Development] sites whose presence is required at a Pfizer location to ensure supply of our medicines and vaccines, critical research and development programs continue, and to maintain and keep secure our labs and buildings as defined by site management.

Once the specific dates for our site have been identified, we will share a more detailed plan and each eligible on-site essential colleague will receive an e-mail from Colleague Wellness (formerly known as Occupational Health & Wellness) with instructions for registering for an on-site appointment to receive your vaccination.

Eligible on-site essential contractors will be notified, either by e-mail or by their Pfizer sponsor, and will receive instructions for registering for an on-site appointment as well.

The vaccine doses to be used for this program are separate and distinct from those committed by Pfizer to governments around the world and will not impact supply to national governments in any way.

Credit: InfoWars

The Newbridge plant in County Kildare, Ireland, also participated in this initiative, with several hundred employees receiving the Pfizer/BioNTech vaccine.

“The jabs, which are being given to “site-essential” staff, will not affect the supply being rolled out by the HSE as part of its vaccination programme. Around 15,000 staff and contractors at Pfizer plants across the EU will receive the vaccine,” Kildare Live reported in 2021.

Pfizer issued a statement to the news outlet stating:

“Site-essential employees are those based at our manufacturing and R&D sites whose presence is required at a Pfizer location to ensure supply of our medicines and vaccines, the continuation of critical research and development programs, and to maintain and keep secure our labs and buildings.

“Vaccination of site-essential employees started this week at our manufacturing sites in Kalamazoo, Michigan, and Puurs, Belgium. We will expand to other Pfizer sites on a rolling basis.  There are approximately 15,000 employees and contractors across Pfizer sites in the EU who are considered site-essential.

“The vaccine doses to be used for this program are separate and distinct from those committed by Pfizer to governments around the world and will not impact supply to national governments in any way.”

The Gateway Pundit reported last year that during a Senate hearing in Australia, a Pfizer spokesperson revealed that the pharmaceutical giant had imported a special batch of COVID-19 vaccines solely for their employee vaccination program.

The admission came during a rigorous questioning session on Wednesday, in which Pfizer Australia’s Country Medical Director, Dr. Krishan Thiru, and Head of Regulatory Sciences, Dr. Brian Hewitt, spoke before the Australian Senate’s ‘Education and Employment Legislation Committee’ about the experimental COVID-19 vaccines.

Australian Senator Malcolm Roberts led the interrogation with forceful inquiries regarding Pfizer’s potential involvement in the introduction of vaccine mandates for employment in Australia.

Senator Roberts, in his questioning, alleged a significant transfer of wealth from the Australian people to Big Pharma via the government’s Covid-19 mismanagement.

Roberts also asked about Pfizer’s own employee vaccination program, which Dr. Thiru confirmed was active and acknowledged that a small number of colleagues departed the company in light of this program.

Roberts then questioned Pfizer’s use of a specific batch of vaccine for their employees that was not tested by the Therapeutic Goods Administration (TGA), to which Dr. Hewitt CLAIMED that this was done to ensure that no vaccine would be taken from government stocks.

“Pfizer undertook to import a batch of vaccine specifically for the employee vaccination programme, and that was so that no vaccine would be taken from government stocks that was being delivered to clinics as needed,” Hewitt said.

WATCH:

Photo of author
Jim Hᴏft is the founder and editor of The Gateway Pundit, one of the top conservative news outlets in America. Jim was awarded the Reed Irvine Accuracy in Media Award in 2013 and is the proud recipient of the Breitbart Award for Excellence in Online Journalism from the Americans for Prosperity Foundation in May 2016.

You can email Jim Hᴏft here, and read more of Jim Hᴏft's articles here.

 

Thanks for sharing!